Last month, 300 key players from the genomics, precision medicine, and big data space gathered for the crucial annual meeting the BioData World Congress Europe. It provided so much more than just meetings, and was hailed by supporting partners as the cornerstone of dialogue for years to come.
The event series promises to continue at the highest level in 2017. Don’t take my word for it, this is what our attendees say about the BioData Series.
“Inspiring, astonishing and thought provoking in equal measures.” Intel Health
“Truly an important event” SAP
“A really great Congress. We made so many fantastic connections and had a lot of really good meetings at a very high level” Dell EMC
Big data, genomics and AI will be a key focus in the BioData Congress West next April in San Francisco. Supported by the American Heart Association, the Broad Institute, UCSF, the Farr Institute and others, San Francisco hails the debut of the Artificial Intelligence for Drug Discovery, Biomarker Development and Aging Research stream run by Alex Zhavoronkov, CSO, InSilico Medicine.